Vaccine dosage from manufacturer Johnson & JohnsonBuilt in: Getty Images North America / AFP / Archive / Mario Tama
US vaccine maker Johnson & Johnson (J&J) has announced that it will supply up to 400 million vaccines to African countries. “No one is safe before everyone is safe, and we have an obligation to make corona vaccines globally accessible,” company boss Alex Korsky said Monday. Availability of the site is subject to the respective approvals of the 55 countries of the African Union.
The U.S. agency says the first deliveries of the vaccine, unlike other corona vaccines, should only be administered once and should arrive in the third quarter of this year. The wholesaler Jansen Pharmaceuticals has agreed with the African Vaccine Acquisition Foundation (AWAT) to provide a total dose of 220 million. Avad can order a further 180 cans.
According to the company, the J&J vaccine protects against coronavirus mutations. The global study with approximately 40,000 participants showed 85.4 percent performance against rigorous courses and 66 percent for moderate courses. Unlike competing products, the vaccine does not require much cooling, which facilitates transportation and distribution.
© 2021 AFP